Humanigen CEO Receives PharmaVOICE 100 Red Jacket Award
11 août 2017 08h00 HE
|
Humanigen, Inc.
BRISBANE, Calif., Aug. 11, 2017 (GLOBE NEWSWIRE) -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, today...
Humanigen Announces Completion of Benznidazole Bioavailability Study
08 août 2017 08h00 HE
|
Humanigen, Inc.
BRISBANE, Calif., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, today...
Humanigen, Inc. Is Effective Today
07 août 2017 07h00 HE
|
Humanigen, Inc.
BRISBANE, Calif., Aug. 07, 2017 (GLOBE NEWSWIRE) -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, today...
KaloBios To Change Company Name To Humanigen, Inc.
27 juil. 2017 16h37 HE
|
KaloBios Pharmaceuticals Inc.
Transforming company with focus and commitment on neglected and rare diseases Continue to expect New Drug Application (NDA) submission for benznidazole in Chagas disease to FDA in first quarter 2018 ...
KaloBios Receives $5.0M in New Funding Commitment From Existing Investors
12 juil. 2017 16h10 HE
|
KaloBios Pharmaceuticals Inc.
BRISBANE, Calif., July 12, 2017 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTCQB:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...
KaloBios Receives Orphan Drug Designation for Benznidazole in the Treatment of Chagas Disease
11 juil. 2017 17h36 HE
|
KaloBios Pharmaceuticals Inc.
BRISBANE, Calif., July 11, 2017 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTCQB:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...
Benznidazole IND for Chagas Disease Receives Clearance by FDA
27 juin 2017 08h00 HE
|
KaloBios Pharmaceuticals Inc.
Open IND is a significant step to advancing the benznidazole development programCompany remains on track to submit a New Drug Application in the first quarter of 2018 BRISBANE, Calif., June 27,...
KaloBios Upgrades Stock to OTCQB Market
26 juin 2017 07h00 HE
|
KaloBios Pharmaceuticals Inc.
BRISBANE, Calif., June 26, 2017 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTCQB: KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...
KaloBios CEO to Present at Two Upcoming Investor Conferences
31 mai 2017 08h00 HE
|
KaloBios Pharmaceuticals Inc.
BRISBANE, Calif., May 31, 2017 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...
KaloBios Submits IND Application for Benznidazole to FDA
30 mai 2017 08h00 HE
|
KaloBios Pharmaceuticals Inc.
BRISBANE, Calif., May 30, 2017 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...